CARISMA THERAPEUTICS INC closed fiscal year 2024 with $30.5M in total assets, $58.4M in total liabilities and -$27.9M in shareholder equity. This represents a decrease of 66.0% from the prior fiscal year. The table below carries 13 fiscal years, from 2012 to 2024, and the quarters CARISMA THERAPEUTICS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CARM Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.5M-66.0% | $89.6M+24.1% | $72.2M-70.0% | $240.7M+96.0% | $122.8M+7.4% | $114.4M+2.5% | $111.6M+48.6% | $75.1M-27.9% | $104.1M+182.7% | $36.8M-33.0% | $55.0M+389.5% | $11.2M | N/A |
| Total Liabilities | $58.4M-7.4% | $63.0M-72.5% | $229.2M+232.0% | $69.0M-47.7% | $132.1M-6.4% | $141.1M+109.4% | $67.4M+18.0% | $57.1M-12.8% | $65.4M+265.9% | $17.9M-1.6% | $18.2M-72.3% | $65.6M | N/A |
| Total Equity | -$27.9M-205.2% | $26.5M+116.9% | -$157.1M-191.5% | $171.7M+1961.0% | -$9.2M+65.4% | -$26.7M-160.4% | $44.2M+145.1% | $18.0M-53.4% | $38.7M+104.2% | $18.9M-48.6% | $36.8M+167.8% | -$54.3M-38.3% | -$39.3M |
CARM Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.6M-84.4% | $5.0M-91.6% | $16.0M-78.4% | $30.5M-66.0% | $42.1M-60.6% | $59.3M-55.4% | $73.8M-52.7% | $89.6M+24.1% | $106.8M-46.5% | $133.0M-24.5% | $156.1M-30.9% | $72.2M-70.0% |
| Total Liabilities | $7.4M-86.0% | $51.0M-13.5% | $52.6M-16.4% | $58.4M-7.4% | $53.2M-12.1% | $59.0M-11.1% | $62.9M-10.2% | $63.0M-72.5% | $60.5M+74.3% | $66.3M+96.1% | $70.1M+32.1% | $229.2M+232.0% |
| Total Equity | -$867K+92.2% | -$46.0M-12879.2% | -$36.7M-436.5% | -$27.9M-205.2% | -$11.1M-124.0% | $360K-99.5% | $10.9M-87.3% | $26.5M+116.9% | $46.3M-71.9% | $66.7M-53.1% | $86.1M-50.2% | -$157.1M-191.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More CARISMA THERAPEUTICS INC financials
Frequently Asked Questions
What was CARISMA THERAPEUTICS INC's total assets in fiscal year 2024?
CARISMA THERAPEUTICS INC closed fiscal year 2024 with $30.5M in total assets, $58.4M in total liabilities and -$27.9M in shareholder equity.
How fast is CARISMA THERAPEUTICS INC's total assets growing?
CARISMA THERAPEUTICS INC (CARM) total assets fell by 66.0% year over year, from $89.6M to $30.5M in fiscal year 2024.
What was CARISMA THERAPEUTICS INC's total assets in the most recent quarter?
CARISMA THERAPEUTICS INC (CARM) reported $6.6M in total assets in Q3 2025. This represents a decrease of 84.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what CARISMA THERAPEUTICS INC (CARM) reported on that line in every period on record.